About: Corbus Pharmaceuticals Holdings, Inc., a clinical stage company, develops and commercializes therapeutics for cancer and obesity. Its pipeline includes CRB-701, an antibody drug conjugate that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload of monomethyl auristatin E; and CRB-913, a peripherally restricted cannabinoid type-1 receptor inverse agonist for the treatment of obesity. The company was incorporated in 2009 and is headquartered in Norwood, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Latest price: $2.44 (-11.29%)
CRBP NASDAQ Corbus Pharmaceuticals Holding
Corbus Pharmaceuticals Holding share price
CRBP price activity
Last Price
$2.440
Change (24hr)
-0.31 USD (11.29%)
Volume
622.81K
Volume (4w avg)
-
Open
$2.72
Day Range
$2.42 - $2.88
Previous Close
$2.75
Last Trade
19 Nov, 9:00 pm GMT+0
Delayed
19 Nov, 9:00 pm GMT+0
CRBP price performance
Delayed
19 Nov, 9:00 pm GMT+0
CRBP details
CRBP Market Signals